Skip to main content
. 2022 Apr 5;42(9):2847–2854. doi: 10.1007/s10792-022-02275-9

Table 3.

Dynamic pupillary light responses in healthy control participants and post-COVID-19 subjects with and without neurological symptoms at 4 weeks

Healthy controls (n = 30) With neurological symptoms at 4 weeks (n = 16) Without neurological symptoms at 4 weeks (n = 19) P values
With neurological symptoms versus control Without neurological symptoms versus control With versus without neurological symptoms
Initial pupil diameter (mm) 5.66 ± 0.84 5.58 ± 0.78 5.66 ± 0.97 0.955a 0.999a 0.961a
Amplitude of contraction (mm) 1.83 ± 0.29 1.71 ± 0.30 1.78 ± 0.37 0.414a 0.812a 0.803a
Latency of contraction (ms) 258.0 (234.8–276.5) 285.5 (266.8–300.5) 283.0 (273.0–311.0) 0.016b 0.010b  > 0.999b
Duration of contraction (ms) 662.3 ± 89.2 576.8 ± 81.2 645.7 ± 93.4 0.008a 0.800a 0.064a
Velocity of contraction (mm/s) 5.67 ± 0.94 5.59 ± 0.92 5.38 ± 1.04 0.965a 0.577a 0.801a
Latency of dilation (ms) 911.4 ± 80.0 861.5 ± 76.0 918.6 ± 105.0 0.162a 0.958a 0.139a
Duration of dilation (ms) 1575.6 ± 86.3 1602.4 ± 97.8 1553.5 ± 108.8 0.641a 0.715a 0.298a
Velocity of dilation (mm/s) 1.69 (1.52–1.84) 1.58 (1.46–1.76) 1.59 (1.27–1.64) 0.172b*

Data are expressed as mean ± SD for parametric variables and median (IQR) for non-parametric variables. The bold P values represent statistically significant differences

*Pairwise comparisons were not performed as the overall test did not show a significant difference among groups

aOne-way ANOVA test followed by post-hoc Tukey test, bKruskal–Wallis test followed by post-hoc Dunn’s test with adjusted P values using Benjamini–Hochberg procedure

HHS Vulnerability Disclosure